Blood holds clues to rectal Cancer's future
NCT ID NCT02874885
Summary
This study aims to learn if tiny pieces of cancer floating in the blood can help doctors understand how rectal cancer responds to treatment. Researchers are collecting blood samples from 341 patients with rectal cancer and some healthy volunteers to track these 'circulating tumor elements' over time. The goal is to see if these blood markers can predict a patient's risk and how well their treatment is working.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.